MedPath

Elements Vital to Treat Obesity Study

Not Applicable
Recruiting
Conditions
Obesity
Interventions
Behavioral: Smartphone App Participants (APP)
Behavioral: Diabetes Prevention Program Participants (DPP)
Registration Number
NCT04708769
Lead Sponsor
Northwestern University
Brief Summary

The overall objective of this study is to evaluate the first rigorously optimized, remotely delivered treatment for obesity against the current gold standard treatment in a head-to-head randomized controlled trial. The investigators will be comparing the previously developed and optimized behavioral weight loss intervention (APP) to the Diabetes Prevention Program (DPP), to evaluate program weight-loss success and cost-effectiveness.

Detailed Description

The proposed study seeks to determine if the APP program is an effective, resource-sensitive strategy to manage weight for obesity, as compared to the DPP program. During the 24-week active intervention phase, participants will be randomized to one of two treatments: 1) APP, wherein participants receive calorie, fat, and physical activity goals via a Smartphone application for self-monitoring, online educational readings, and biweekly sessions with a Health Promotionist; or 2) DPP, wherein participants are guided to self-monitor their physical activity, food intake, and weight via a participant log, and are guided through 16 sessions by a Health Promotionist. Assessments to track progress will occur remotely at the 3-month, 6-month, and 12-month time points of the program.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
524
Inclusion Criteria
  • BMI 30-45
  • Weight stable
  • Own a Smartphone and be willing to install our Smartphone app
  • Willing to conduct video conference calls with study staff
Exclusion Criteria
  • Enrolled in any formal weight loss program
  • Taking anti-obesity medications
  • Not taking medications that may cause weight gain
  • Unstable medical conditions
  • Diabetes requiring insulin supplementation
  • Crohn's Disease
  • Diagnosis of obstructive sleep apnea requiring intervention (i.e., CPAP)
  • Assistive devices for mobility
  • Hospitalizations for a psychiatric disorder within the past 5 years
  • Cardiovascular disease symptoms while performing moderate intensity exercise
  • Pregnancy, trying to get pregnant, or lactating.
  • Bulimia or binge eating disorder
  • Reports of active suicidal ideation
  • Current substance abuse or dependence besides nicotine dependence

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Smartphone App Participants (APP)Smartphone App Participants (APP)Smartphone application, diet and activity goals, online lessons, brief remote sessions with a Health Promotionist
Diabetes Prevention Program Participants (DPP)Diabetes Prevention Program Participants (DPP)Participant program manual, diet and activity logs, hour long remote sessions with a Health Promotionist
Primary Outcome Measures
NameTimeMethod
WeightBaseline to 6-Months

Participant change in weight, in kilograms, from baseline to 6-months.

Secondary Outcome Measures
NameTimeMethod
Costs of treatment12 Months

Costs of EVO versus DPP implementation

Trial Locations

Locations (1)

Northwestern University

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath